Search Page

1

Cite

Share

Cyclooxygenase-2 in lung cancer.

Dubinett SM, Sharma S, Huang M, Dohadwala M, Pold M, Mao JT. Dubinett SM, et al. Among authors: mao jt. Prog Exp Tumor Res. 2003;37:138-62. doi: 10.1159/000071371. Prog Exp Tumor Res. 2003. PMID: 12795053 Review. No abstract available.

Cite

Share

2

Cite

Share

Strategies for pacemaker programming in acute heart failure.

Lahiri MK, Mao JT, Schuger CD. Lahiri MK, et al. Among authors: mao jt. Heart Fail Rev. 2011 Sep;16(5):441-8. doi: 10.1007/s10741-011-9239-1. Heart Fail Rev. 2011. PMID: 21400230 Review.

Cite

Share

3

Cite

Share

Cancer and inflammation: promise for biologic therapy.

Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, Abraham RT, Carbone M, Lotze MT. Demaria S, et al. Among authors: mao jt. J Immunother. 2010 May;33(4):335-51. doi: 10.1097/CJI.0b013e3181d32e74. J Immunother. 2010. PMID: 20386472 Free PMC article. Review.

Cite

Share

4

Cite

Share

Multifaceted roles of cyclooxygenase-2 in lung cancer.

Riedl K, Krysan K, Põld M, Dalwadi H, Heuze-Vourc'h N, Dohadwala M, Liu M, Cui X, Figlin R, Mao JT, Strieter R, Sharma S, Dubinett SM. Riedl K, et al. Among authors: mao jt. Drug Resist Updat. 2004 Jun;7(3):169-84. doi: 10.1016/j.drup.2004.04.003. Drug Resist Updat. 2004. PMID: 15296859 Review.

Cite

Share

5

Cite

Share

Chemoprevention strategies with cyclooxygenase-2 inhibitors for lung cancer.

Mao JT, Cui X, Reckamp K, Liu M, Krysan K, Dalwadi H, Sharma S, Hazra S, Strieter R, Gardner B, Dubinett SM. Mao JT, et al. Clin Lung Cancer. 2005 Jul;7(1):30-9. doi: 10.3816/CLC.2005.n.019. Clin Lung Cancer. 2005. PMID: 16098242 Review.

Cite

Share

6

Cite

Share

Leucoselect Phytosome Modulates Serum Eicosapentaenoic Acid, Docosahexaenoic Acid, and Prostaglandin E3 in a Phase I Lung Cancer Chemoprevention Study.

Mao JT, Xue B, Fan S, Neis P, Qualls C, Massie L, Fiehn O. Mao JT, et al. Cancer Prev Res (Phila). 2021 Jun;14(6):619-626. doi: 10.1158/1940-6207.CAPR-20-0585. Epub 2021 Mar 11. Cancer Prev Res (Phila). 2021. PMID: 33707173 Free PMC article. Clinical Trial.

Cite

Share

7

Cite

Share

Percutaneous biliary stent combined with brachytherapy using ¹²⁵I seeds for treatment of unresectable malignant obstructive jaundice: A meta-analysis.

Chen WY, Kong CL, Meng MM, Chen WQ, Zheng LY, Mao JT, Fang SJ, Chen L, Shu GF, Yang Y, Weng QY, Chen MJ, Xu M, Ji JS. Chen WY, et al. Among authors: mao jt. World J Clin Cases. 2021 Dec 16;9(35):10979-10993. doi: 10.12998/wjcc.v9.i35.10979. World J Clin Cases. 2021. PMID: 35047608 Free PMC article.

Cite

Share

8

Cite

Share

Inflammation and lung carcinogenesis: applying findings in prevention and treatment.

Peebles KA, Lee JM, Mao JT, Hazra S, Reckamp KL, Krysan K, Dohadwala M, Heinrich EL, Walser TC, Cui X, Baratelli FE, Garon E, Sharma S, Dubinett SM. Peebles KA, et al. Among authors: mao jt. Expert Rev Anticancer Ther. 2007 Oct;7(10):1405-21. doi: 10.1586/14737140.7.10.1405. Expert Rev Anticancer Ther. 2007. PMID: 17944566 Review.

Cite

Share

9

Cite

Share

Inflammation in lung carcinogenesis: new targets for lung cancer chemoprevention and treatment.

Lee JM, Yanagawa J, Peebles KA, Sharma S, Mao JT, Dubinett SM. Lee JM, et al. Among authors: mao jt. Crit Rev Oncol Hematol. 2008 Jun;66(3):208-17. doi: 10.1016/j.critrevonc.2008.01.004. Epub 2008 Mar 4. Crit Rev Oncol Hematol. 2008. PMID: 18304833 Free PMC article. Review.

Cite

Share

10

Cite

Share

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

Szabo E, Mao JT, Lam S, Reid ME, Keith RL. Szabo E, et al. Among authors: mao jt. Chest. 2013 May;143(5 Suppl):e40S-e60S. doi: 10.1378/chest.12-2348. Chest. 2013. PMID: 23649449 Free PMC article. Review.

Cite

Share